Showing results (1531-1540 of 6,719) with videos related to

Sort By:
Pageof 672
Annals of Hematology|October 23, 2024
Aplastic Anemia in the light of the COVID-19 pandemic: infection, vaccination, and pathophysiologic mechanismsNelson Luis Cahuapaza-Gutierrez
Annals of Hematology|October 25, 2024
Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemiaMaximilian Fleischmann, Madlen Jentzsch, Annamaria Brioli, et al.
Annals of Hematology|October 25, 2024
Non-linear relationship between soluble interleukin-2 receptor and prognosis of diffuse large B-cell lymphomaHikaru Tsukasaki, Kei Fujita, Shin Lee, et al.
Annals of Hematology|October 22, 2024
Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experienceBenjamin J Lee, Shawn P Griffin, Jean Doh, et al.
Annals of Hematology|October 22, 2024
Health-related quality of life benefits of arsenic trioxide in patients with non-high-risk acute promyelocytic leukemia are sustained over time: long-term results of the GIMEMA APL0406 trialFabio Efficace, Francesco Sparano, Massimo Breccia, et al.
Annals of Hematology|May 29, 2026
A macrophage-related efferocytosis-based two-gene prognostic model for acute myeloid leukemia identified by multi-omics and machine learningXiaoning Li, Yujie Zhang, Xiaoying Wei, et al.
Annals of Hematology|May 29, 2026
Identification and validation of a prognostic risk-scoring model in drug-resistant ALL and evaluation of immune micro-environmentYun-Yao Li, Hong-Xi Huang, Jian-Wei Guan, et al.
Annals of Hematology|May 13, 2026
Expanding the genetic spectrum of hereditary spherocytosis: novel mutations and phenotypic heterogeneity from a 55-patient cohortHuiying Shu, Liqing Yang, Yu Gao, et al.
Annals of Hematology|May 23, 2026
Bioinformatics-driven dissection of PANoptosis-related molecular subtypes and tumor immune microenvironment heterogeneity in pediatric acute myeloid leukemiaWen-Ting Pei, Chun-Lei Liu, Xiao-Ling Li
Annals of Hematology|May 22, 2026
Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemiaSeok Lee, Hyeoung-Joon Kim, June-Won Cheong, et al.
Pageof 672